Pandora, Gap Post R...
Health Care: Drugs
Oncothyreon Inc. (ONTY: NASDAQ)
$1.95 -0.01 | -0.51%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 22.27M | 11.61M | 5.51M | 18.97M |
| Receivables | 323.00K | 321.00K | 620.00K | 77.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 82.42M | 64.81M | 30.08M | 33.53M |
| Property, Plant & Equipment, Gross | 4.03M | 3.30M | 3.16M | 2.90M |
| Accumulated Depreciation & Depletion | 2.15M | 1.66M | 1.20M | 827.00K |
| Property, Plant & Equipment, Net | 1.89M | 1.64M | 1.96M | 2.08M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 3.01M | 2.78M | 290.00K | 504.00K |
| Total Non-Current Assets | 7.02M | 6.54M | 4.36M | 4.70M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 89.44M | 71.35M | 34.44M | 38.22M |
| Accounts Payable | 1.13M | 459.00K | 624.00K | 600.00K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 44.00K | 329.00K | 0.00 | 0.00 |
| Total Current Liabilities | 3.07M | 4.68M | 1.86M | 2.08M |
| Long Term Debt | 0.00 | 3.06M | 199.00K | 199.00K |
| Deferred Income Taxes | 533.00K | 617.00K | 388.00K | 295.00K |
| Other Non-Current Liabilities | 3.51M | 29.56M | 13.11M | 10.21M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 4.04M | 33.24M | 13.73M | 10.73M |
| Total Liabilities | 7.11M | 37.92M | 15.59M | 12.81M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 82.32M | 33.43M | 18.86M | 25.42M |
| Common Par | 353.85M | 353.85M | 353.85M | 345.84M |
| Additional Paid In Capital | 126.83M | 74.54M | 17.33M | 16.28M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -393.33M | -389.91M | -347.26M | -331.64M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -5.04M | -5.04M | -5.07M | -5.07M |
| Total Capitalization | 82.32M | 36.49M | 19.06M | 25.62M |
| Total Equity | 82.32M | 33.43M | 18.86M | 25.42M |
| Total Liabilities & Stock Equity | 89.44M | 71.35M | 34.44M | 38.22M |
| Total Common Shares Outstanding | 57.22M | 43.61M | 30.09M | 25.75M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 53.73M | 38.20M | 26.89M | 22.74M |
| Diluted Weighted Shares Outstanding | 54.90M | 38.20M | 26.89M | 22.74M |
| Number of Employees | 42 | 32 | 25 | 16 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ONTY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorBreakout Stocks Of The Week...
Latest ONTY Headlines from TheStreet
- 4 Biotech Stocks Under $10 Making Big Moves 04.09.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
- Biotech Stock Mailbag: Amicus, Amarin, Oncothyreon 12.21.12 | 07:12 am
- Stocks Slip as Pessimism Clouds Fiscal-Cliff Talks 12.19.12 | 02:12 pm
- Oncothyreon: A Failed Drug Autopsy Performed By A Short Seller 12.19.12 | 10:12 am
- Stock Futures Rise Ahead of Housing Data 12.19.12 | 07:12 am
- Merck KGaA, Oncothyreon Lung Cancer Drug Fails Late-Stage Study 12.19.12 | 06:12 am
- 4 More Stocks Leaping on Unusual Volume 12.11.12 | 03:12 pm
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
Press Releases for ONTY
- Oncothyreon To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.29.13 | 08:03 am
- Oncothyreon Announces Full Year And Fourth Quarter 2012 Financial Results Conference Call - PR Newswire 03.07.13 | 08:03 am
- Oncothyreon To Present At Cowen And Company 33rd Annual Health Care Conference - PR Newswire 02.27.13 | 08:02 am
- Oncothyreon Announces That L-BLP25 (Stimuvax®) Did Not Meet Primary Endpoint Of Improvement In Overall Survival In Pivotal Phase 3 Trial In Patients With Non-Small Cell Lung Cancer - PR Newswire 12.19.12 | 06:12 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In November 2012 - PR Newswire 11.07.12 | 08:11 am
- Oncothyreon Announces Third Quarter 2012 Financial Results Conference Call - PR Newswire 10.31.12 | 08:10 am
- Oncothyreon Expands Phase 2 Trial Of Its PI-3 Kinase Inhibitor PX-866 In Patients With Prostate Cancer - PR Newswire 09.05.12 | 08:09 am
- Oncothyreon Announces Presentations At Upcoming Investment Conferences In September 2012 - PR Newswire 08.29.12 | 08:08 am
- Oncothyreon Announces Second Quarter 2012 Financial Results Conference Call - PR Newswire 08.08.12 | 08:08 am
- Oncothyreon To Present At 2012 Wedbush Pacgrow Lifesciences Management Access Conference - PR Newswire 08.08.12 | 08:08 am
Partner Headlines for ONTY
- Stock Watch Thursday, 20 December - Seeking Alpha 12.20.12 | 09:12 am
- Long term spread targets Oncothyreon - NASDAQ 08.30.12 | 04:08 pm
- Reassessing & Continuing To Monitor Portfolios For Success - Seeking Alpha 07.30.12 | 09:07 am
- Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting - Benzinga 06.02.12 | 06:06 pm
- Must Know Equity Upgrades and Downgrades Wednesday - Wall St. Cheat Sheet 05.23.12 | 03:05 am
- Interesting Reaction To Oncothyreon's Share Offering - Seeking Alpha 03.30.12 | 08:03 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Oncothyreon And Lpath: Shares Collapsed, Primed For A Rebound? - Seeking Alpha 03.09.12 | 09:03 am
- Immunocellular Again Pushing To $2 - Seeking Alpha 02.15.12 | 09:02 am
- Stocks To Watch Week Of Feb. 6 - Seeking Alpha 02.06.12 | 08:02 am
